JPS5640608A - Pharmaceutical preparation for rectal administration - Google Patents

Pharmaceutical preparation for rectal administration

Info

Publication number
JPS5640608A
JPS5640608A JP11569679A JP11569679A JPS5640608A JP S5640608 A JPS5640608 A JP S5640608A JP 11569679 A JP11569679 A JP 11569679A JP 11569679 A JP11569679 A JP 11569679A JP S5640608 A JPS5640608 A JP S5640608A
Authority
JP
Japan
Prior art keywords
pharmaceutical preparation
rectal administration
microcapsules
absorption
ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP11569679A
Other languages
Japanese (ja)
Inventor
Mitsuo Mazaki
Hiroshi Kashihara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Chemiphar Co Ltd
Original Assignee
Nippon Chemiphar Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Chemiphar Co Ltd filed Critical Nippon Chemiphar Co Ltd
Priority to JP11569679A priority Critical patent/JPS5640608A/en
Publication of JPS5640608A publication Critical patent/JPS5640608A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

PURPOSE: A pharmaceutical preparation for rectal administration with the duration of action improved by prolonging the absorption of an active ingredient, being obtained by compounding the microcapsules of the ingredient with a base, etc. together.
CONSTITUTION: A pharmaceutical preparation for rectal administration having the prolonged absorption of an active ingredient, consisting of the ingredient, e.g., indomethacin, diclofenac sodium, aspirin, and 1-(2'-tetrahydrofuryl)-5-fluorouracil, in the form of microcapsules, one or more bases selected from polyethylene glycol, cacao butter, Tween, Witepsol (manufactured by Chemische Werke Witten), etc., and, if desired, additives such as a preservative, a surface active agent, an antioxidant and a coloring agent. The coating material of the microcapsules is e.g., polyhexamethylene terephthalamide or polyhexamethylene sebacamide. Since the absorption of an active ingredient from the rectum is prolonged, the long duration of action, improvement in safety, decrease in administration rate, etc. can be achieved.
COPYRIGHT: (C)1981,JPO&Japio
JP11569679A 1979-09-11 1979-09-11 Pharmaceutical preparation for rectal administration Pending JPS5640608A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP11569679A JPS5640608A (en) 1979-09-11 1979-09-11 Pharmaceutical preparation for rectal administration

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11569679A JPS5640608A (en) 1979-09-11 1979-09-11 Pharmaceutical preparation for rectal administration

Publications (1)

Publication Number Publication Date
JPS5640608A true JPS5640608A (en) 1981-04-16

Family

ID=14668968

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11569679A Pending JPS5640608A (en) 1979-09-11 1979-09-11 Pharmaceutical preparation for rectal administration

Country Status (1)

Country Link
JP (1) JPS5640608A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05194223A (en) * 1992-09-11 1993-08-03 Kyorin Pharmaceut Co Ltd Sustained release suppository composition for 3-isobutyryl-2-isopropylpyrazolo(1,5-a)pyridine
WO2002003954A3 (en) * 2000-07-07 2002-05-10 Anestic Aps Non swellable suppository comprising at least one biocompatible, non-biodegradable polymer and a controlled release formulation

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05194223A (en) * 1992-09-11 1993-08-03 Kyorin Pharmaceut Co Ltd Sustained release suppository composition for 3-isobutyryl-2-isopropylpyrazolo(1,5-a)pyridine
WO2002003954A3 (en) * 2000-07-07 2002-05-10 Anestic Aps Non swellable suppository comprising at least one biocompatible, non-biodegradable polymer and a controlled release formulation

Similar Documents

Publication Publication Date Title
CA2105180A1 (en) Compositions containing sumatriptan
ES8307794A1 (en) Antifungal agents, processes for their preparation, and pharmaceutical compositions containing them.
IE862554L (en) Pharmaceutical compositions
IL53594A (en) Biological cells comprising pharmaceutically active substances and additives controlling their release from the cells,their preparation and pharmaceutical compositions containing them
MY100359A (en) External pharmaceutical composition.
MY101791A (en) New benzimidazole derivatives
HUT51218A (en) Herbicides comprising acylated 1,3-dicarbonyl derivatives as active ingredient and compositions containing antidotes as well
IT1190824B (en) PHARMACEUTICAL COMPOSITION CONTAINING 24.25-DIHYDROXICOLECALCIFEROL AS ACTIVE INGREDIENT
ES8303092A1 (en) Antifungal compositions with a higher rate of the drug release as a stick.
DE3364234D1 (en) Antiphlogistic/antipyretic/analgesic pharmaceutical compositions containing theophylline derivatives as active ingredient
ES2020171T3 (en) 1-BENZYL-3-HYDROXYMETHYLINDAZOLE ETHERS WITH 2-ALIPHATIC HYDROXIACIDES.
NO910874L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PIPERIDE INGREDIENTS.
JPS5640608A (en) Pharmaceutical preparation for rectal administration
IL65445A0 (en) New derivatives of phenyl aliphatic carboxylic acids,their preparation,their use as medicaments and the compositions containing them
IL49931A (en) Pharmaceutical compositions comprising 1-phenyl-2,3,4,5-tetrahydro-1h-benzazepine derivatives and certain new such compounds
SE9403389D0 (en) Pharmaceutical composition containing derivatives of sex hormones
MX9203615A (en) PHARMACEUTICAL COMPOSITION IN THE FORM OF POWDER FOR NASAL ADMINISTRATION.
GB2021409A (en) Pharmaceutical composition
PT80961A (en) Process for the preparation of new pharmaceutical compounds containing mixtures of 4,9-dihydro-4-(1-methyl-4-piperydilene)-10h-benzoý4,5¨-cycloheptaý1,2-b¨thyophene-10-one and antiasthmati c xantines as active ingredient
JPS5366420A (en) Insecticide against maggots
JPS5668619A (en) Nifedipine-containing solid composition
ES8504166A1 (en) 6,11-Dihydro-11,-oxo-dibenz(b,e)-oxepin derivatives, methods for their preparation, pharmaceutical compositions containing the same and their use as medicaments.
JPS577410A (en) Plaster
JPS57209215A (en) Antiphlogistic composition
SE393930B (en) BACTERIC AND FUNGICIDE MEASURES, WHICH, AS THE ACTIVE INGREDIENT, CONSIST OF A MIXTURE OF (1) CERTAIN TERMINAL PRODUCTS OF BENZYL ALCOHOLS WITH FORMALDEHYDE AND (2) PHENOLES